PBH vs. HYG

In the year-to-date period, PBH achieves a 11.79% return, which is significantly higher than HYG's 1.81% return. Over the past 10 years, PBH has outperformed HYG with an annualized return of 7.84%, while HYG has yielded a comparatively lower 3.96% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Prestige Consumer Healthcare Inc. (PBH) and iShares iBoxx $ High Yield Corporate Bond ETF (HYG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current PBH Sharpe Ratio is 0.87, which is lower than the HYG Sharpe Ratio of 1.45. The chart below compares the historical Sharpe Ratios of PBH and HYG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

PBH has not paid dividends to shareholders, while HYG's dividend yield for the trailing twelve months is around 5.89%.

The maximum PBH drawdown since its inception was -80.60%, which is greater than HYG's maximum drawdown of -34.24%. Use the drawdown chart below to compare losses from any high point for PBH and HYG. For additional features, visit the drawdowns tool.

Prestige Consumer Healthcare Inc. (PBH) has a higher volatility of 9.66% compared to iShares iBoxx $ High Yield Corporate Bond ETF (HYG) at 2.38%. This indicates that PBH's price experiences larger fluctuations and is considered to be riskier than HYG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.